Bleeding diathesis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 19: Line 19:
! colspan="5" |Clinical manifestation
! colspan="5" |Clinical manifestation
! colspan="5" |Laboratory testing
! colspan="5" |Laboratory testing
! rowspan="2" |Comments
|-
|-
!'''Petechiae'''
!'''Petechiae'''
Line 31: Line 32:
!Thrombin time (TT)
!Thrombin time (TT)
|-
|-
| rowspan="15" |[[Platelet]] disorders
| rowspan="11" |[[Platelet]] disorders
| rowspan="7" |'''[[Thrombocytopenia]]'''
| rowspan="7" |'''[[Thrombocytopenia]]'''
|[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span>
|[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span>
Line 44: Line 45:
|N
|N
|N
|N
|
|
|
|-
|-
Line 57: Line 59:
|N
|N
|N
|N
|
|
|
|-
|-
Line 67: Line 70:
|
|
|↓
|↓
|
|
|
|
|
Line 83: Line 87:
|N
|N
|N
|N
|
|
|
|-
|-
Line 96: Line 101:
|N
|N
|N
|N
|
|
|
|-
|-
Line 107: Line 113:
|
|
|↑
|↑
|
|
|
|
|
Line 122: Line 129:
|N
|N
|N
|N
|
|
|
|-
|-
Line 140: Line 148:
|
|
|
|-
|-
| rowspan="7" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
| rowspan="3" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|
|
|
|
|
Line 157: Line 167:
|-
|-
|Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span>
|Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span>
|
|
|
|
|
Line 169: Line 180:
|
|
|-
|-
| rowspan="5" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span>
|[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span>
|Easy bruising
|
 
* Easy bruising
[[Epistaxis]]
* [[Epistaxis]]
 
* Oral cavity bleeding
Oral cavity bleeding
* Bleeding after dental extraction/surgery
 
* [[Menorrhagia]]
Bleeding after dental extraction/surgery
* [[Postpartum hemorrhage]]
 
[[Menorrhagia]]
 
[[Postpartum hemorrhage]]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 189: Line 196:
|↑
|↑
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|
Line 242: Line 202:
| rowspan="2" |Vessel wall disorders
| rowspan="2" |Vessel wall disorders
| colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders
| colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders
|
|
|
|
|
Line 255: Line 216:
|-
|-
| colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]]
| colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]]
|
|
|
|
|
Line 269: Line 231:
| rowspan="15" |Coagulation disorders
| rowspan="15" |Coagulation disorders
| colspan="2" |[[Fibrinogen]] deficiency
| colspan="2" |[[Fibrinogen]] deficiency
|
|
|
|
|
Line 282: Line 245:
|-
|-
| colspan="2" |[[Prothrombin deficiency]]
| colspan="2" |[[Prothrombin deficiency]]
|
|
|
|
|
Line 295: Line 259:
|-
|-
| colspan="2" rowspan="1" |[[Factor V deficiency]]
| colspan="2" rowspan="1" |[[Factor V deficiency]]
|
|
|
|
|
Line 308: Line 273:
|-
|-
| colspan="2" rowspan="1" |[[Factor VII deficiency]]
| colspan="2" rowspan="1" |[[Factor VII deficiency]]
|
|
|
|
|
Line 321: Line 287:
|-
|-
| colspan="2" rowspan="1" |[[Factor VIII deficiency]]
| colspan="2" rowspan="1" |[[Factor VIII deficiency]]
|
|
|
|
|
Line 334: Line 301:
|-
|-
| colspan="2" rowspan="1" |Factor IX deficiency
| colspan="2" rowspan="1" |Factor IX deficiency
|
|
|
|
|
Line 347: Line 315:
|-
|-
| colspan="2" rowspan="1" |[[Factor X deficiency]]
| colspan="2" rowspan="1" |[[Factor X deficiency]]
|
|
|
|
|
Line 360: Line 329:
|-
|-
| colspan="2" rowspan="1" |[[Factor XI|Factor XI deficiency]]
| colspan="2" rowspan="1" |[[Factor XI|Factor XI deficiency]]
|
|
|
|
|
Line 373: Line 343:
|-
|-
| colspan="2" rowspan="1" |[[Factor XII|Factor XII deficiency]]
| colspan="2" rowspan="1" |[[Factor XII|Factor XII deficiency]]
|
|
|
|
|
Line 386: Line 357:
|-
|-
| colspan="2" |HK deficiency
| colspan="2" |HK deficiency
|
|
|
|
|
Line 399: Line 371:
|-
|-
| colspan="2" rowspan="1" |[[Prekallikrein]] deficiency
| colspan="2" rowspan="1" |[[Prekallikrein]] deficiency
|
|
|
|
|
Line 412: Line 385:
|-
|-
| colspan="2" rowspan="1" |[[Factor XIII deficiency]]
| colspan="2" rowspan="1" |[[Factor XIII deficiency]]
|
|
|
|
|
Line 437: Line 411:
|Prolonged
|Prolonged
|N
|N
|
|-
|-
|Type B deficiency
|Type B deficiency
Line 454: Line 429:
|↑
|↑
|N
|N
|
|-
|-
|Type C deficiency
|Type C deficiency
Line 469: Line 445:
|↑
|↑
|N
|N
|
|-
|-
| rowspan="4" |Rare diseases
| rowspan="4" |Rare diseases
Line 490: Line 467:
|↑
|↑
|↑
|↑
|
|
|
|-
|-
Line 503: Line 481:
|↑
|↑
|Normal or mildly prolonged
|Normal or mildly prolonged
|
|
|
|-
|-
| colspan="2" |Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]]
| colspan="2" |Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]]
|
|
|
|
|
Line 520: Line 500:
| colspan="2" |Acquired Inhibitors of Coagulation Factors
| colspan="2" |Acquired Inhibitors of Coagulation Factors
|
|
|
|
|
|
|
|
|
|
|
|
|
|}
==== Different types of Von willebrand diseases can be differentiate from each other based on below table: ====
{| class="wikitable"
|+
!Type of VWD
!Type of factor deficiency
!Prevalence
!Inheritance pattern
!Clinical manifestations
!VWF activity
!RIPA
!Factor VIII
!Plt levels
!
|-
|type 1
|Quantitative/ partial
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|

Revision as of 13:48, 30 August 2018


Bleeding diathesis main page

Overview

Classification

Differential Diagnosis

Platelet disorders
Immune Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
Hemolytic Uremic Syndrome
Thrombocytosis
Von Willebrand Disease
Coagulation disorders
Fibrinogen deficiency
Prothrombin deficiency
Factor V deficiency
Factor VII deficiency
Factor VIII deficiency
Factor IX deficiency
Factor X deficiency
Factor XI deficiency
Factor XII deficiency
High-molecular-weight kininogen deficiency
Prekallikrein deficiency
Factor XIII deficiency
Hemophilia
Rare diseases
Disseminated Intravascular Coagulation
Vitamin K Deficiency

Different types of Von-Willebrand diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2] Nazia Fuad M.D.

Overview

Bleeding diathesis is unusual susceptibility to bleed due to coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from no symptom to massive symptomatic and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of coagulopathy, there are established laboratory tests that might be used. These laboratory tests such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.

Classification

Differential Diagnosis

Category Sub-category Diseases History Clinical manifestation Laboratory testing Comments
Petechiae Ecchymoses Menorrhagia Hematomas Hemarthrosis platelet count Bleeding time (BT) Prothrombin time (PT) Platelet count activated partial thromboplastin time (aPTT) Thrombin time (TT)
Platelet disorders Thrombocytopenia Infection-Induced Thrombocytopenia + + N N
Medications-Induced Thrombocytopenia History of medications + + N N
Heparin-Induced Thrombocytopenia Trombosis and unexplained thrombocytopenia up to 3 weeks after the end of heparin therapy + +
Immune Thrombocytopenic Purpura (ITP) + + N N
Inherited Thrombocytopenia N N
Thrombotic Thrombocytopenic Purpura (TTP)
Hemolytic Uremic Syndrome N N
Thromobcytosis Digital pain

Gangrene Erythromelalgia

Headache Paresthesias Transient ischemic attacks

+ + ɴormal or slightly prolonged ɴ ɴ
Qualitative Disorders of Platelet Function Inherited Disorders of Platelet Function
Acquired Disorders of Platelet Function
Von Willebrand Disease + + + + + Ν
Vessel wall disorders Metabolic and Inflammatory Disorders
Inherited Disorders of the Vessel Wall
Coagulation disorders Fibrinogen deficiency
Prothrombin deficiency
Factor V deficiency
Factor VII deficiency
Factor VIII deficiency
Factor IX deficiency
Factor X deficiency
Factor XI deficiency
Factor XII deficiency
HK deficiency
Prekallikrein deficiency
Factor XIII deficiency
Hemophilia Type A deficiency Eeasy bruising Inadequate clotting in trauma or mild injury spontaneous hemorrhage. hemarthrosis, epistaxis, gingival bleeding _ _ + + + Unaffected Unaffected Unaffected Prolonged N
Type B deficiency Neonatal bleeding

trauma-related soft-tissue hemorrhage

hemarthrosis and hematomas

_ _ + + + Unaffected N N N
Type C deficiency Family history of bleeding disorder,

bleeding after surgry or injury

_ _ + Rare Rare N N N N
Rare diseases Disseminated Intravascular Coagulation Trauma, burn, crush

Sepsis

Malignancy

Obstetric complication: abruption, amniotic fluid embolism

Hemolytic anemia

+ + _ + +
Vitamin K Deficiency Bleeding after trauma, epistaxis, hematoma, gastrointestinal bleeding, menorrhagia, hematuria, gum bleeding, and oozing from venipuncture sites and easy bruisability + + + + + N Normal or mildly prolonged
Coagulation Disorders Associated with Liver Failure
Acquired Inhibitors of Coagulation Factors

Different types of Von willebrand diseases can be differentiate from each other based on below table:

Type of VWD Type of factor deficiency Prevalence Inheritance pattern Clinical manifestations VWF activity RIPA Factor VIII Plt levels
type 1 Quantitative/ partial